[1] 贾宏军, 郑晓辉, 赵振营. 新版《抗菌药物临床应用指导原则》(2015)的解读[J]. 天津药学, 2016, 28(5): 46-48. [2] 刘亚美, 曹育春. 抗菌药物致药疹65例临床分析[J]. 医药导报, 2019, 38(12): 1601-1604. [3] Zalewska-Janowska A, Spiewak R, Kowalski ML.Cutaneous Manifestation of Drug Allergy and Hypersensitivity[J]. Immunol Allergy Clin North Am, 2017, 37(1): 165-181. [4] 赵娜, 刘伟, 白霞凤. 注射用美罗培南致红皮病型药疹1例[J]. 中国药物警戒, 2019, 16(11): 697-698. [5] 曹媛, 邓蓉蓉, 夏延哲. 36例重型药疹分析[J]. 中国药事, 2016, 30(5): 522-526. [6] 胡廷婷, 徐珽. 硫酸氢氯吡格雷片致大疱表皮松解型药疹1例[J]. 中国药物警戒, 2019, 16(7): 442-443,446. [7] Zhang C, Van DN, Hieu C, et al.Drug-induced severe cutaneous adverse reactions: Determine the cause and prevention[J]. Ann Allergy Asthma Immunol, 2019, 123(5): 483-487. [8] Shenoy ES, Macy E, Rowe T, et al.Evaluation and Management of Penicillin Allergy: A Review[J]. JAMA, 2019, 321(2): 188-199. [9] Kornmehl H, Gorouhi F, Konia T, et al.Generalized fixed drug eruption to piperacillin/tazobactam and review of literature[J]. Dermatol Online J, 2018, 24(4): 14-18. [10] 杨凡萍, 陈圣安, 朱沁媛, 等. 1883例住院药疹患者致敏药物分析[J]. 中华临床免疫和变态反应杂志, 2017, 11(3): 232-240. [11] Jha N, Alexander E, Kanish B, et al.A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab[J]. Indian Dermatol Online J, 2018, 9(5): 299-303. [12] 吴小枫, 林珍, 李扬, 等. 346例药疹病例回顾性分析[J]. 中国药物警戒, 2019, 16(3): 149-153. [13] 卫生部. 糖皮质激素类药物临床应用指导原则(节选)[J]. 药物不良反应杂志, 2011, 13(1): 40-44. [14] 付晓丹, 傅祥评, 杨凡萍, 等. 住院药疹922例临床分析[J]. 中华皮肤科杂志, 2015, 48(12): 867-870. [15] 谢建翔, 张丽. 重症药疹297例分析[J]. 中国医院药学杂志, 2014, 34(3): 247-249. [16] 伍伟, 唐彪, 宋家俊, 等. 344例药疹住院患者临床分析[J]. 皖南医学院学报, 2019, 38(6): 546-548. [17] 李捷, 毛曼云, 唐妮, 等. 126例重症药疹住院患者的临床特征及预后[J]. 中南大学学报(医学版), 2017, 42(8): 953-957. [18] Thakkar S, Patel TK, Vahora R, et al.Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study[J]. Indian J Dermatol, 2017, 62(6): 618-625. [19] Demoly P, Adkinson NF, Brockow K, et al.International Consensus on drug allergy[J]. Allergy, 2014, 69(4): 420-437. [20] Demoly P, Castells M.Important questions in drug allergy and hypersensitivity: consensus papers from the 2018 AAAAI/WAO international drug allergy symposium[J]. World Allergy Organ J, 2018, 11(1): 42-46. [21] Bircher AJ, Scherer K.Delayed cutaneous manifestations of drug hypersensitivity[J]. Med Clin North Am, 2010, 94(4): 711-725. [22] Deng Y, Li S, Zhang L, et al.Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in Asian populations: A meta-analysis[J]. Seizure, 2018, 60(8): 163-171. [23] 陈梦, 李伟, 王雪, 等. 药物类过敏反应发生机制及临床前评价方法研究进展[J]. 中国新药杂志, 2017, 26(1): 51-59. [24] 中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 中华肝脏病杂志, 2015, 23(11): 810-820. [25] 庞宁, 郭代红, 寇炜, 等. 奥美拉唑相关肝功能异常与肝损害的自动监测对比研究[J]. 中国药物警戒, 2019, 16(4): 219-222. [26] European Association for the Study of the Liver. Electronic Address E E E, Clinical Practice Guideline Panel C, Panel M, et al. EASL Clinical Practice Guidelines: Drug-induced liver injury[J]. J Hepatol, 2019, 70(6): 1222-1261. [27] 贾东岗, 赵婉珍, 雷招宝. 阿莫西林-克拉维酸钾的肝毒性反应[J]. 药物不良反应杂志, 2010, 12(1): 37-41. [28] Salvo F, Polimeni G, Moretti U, et al.Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy[J]. J Antimicrob Chemother, 2007, 60(1): 121-126. [29] 崔黎. 阿莫西林与阿莫西林-克拉维酸钾临床不良反应对比分析[J]. 临床医药文献电子杂志, 2019, 6(71): 166,176. [30] 胡俊华, 孟秋媛, 胡艳秋. 阿莫西林与阿莫西林-克拉维酸钾不良反应的对比研究[J]. 中国初级卫生保健, 2018, 32(4): 74-75. [31] 刘皈阳, 于锋英, 陈超, 等. 阿莫西林与阿莫西林-克拉维酸钾不良反应的对比研究[J]. 药物不良反应杂志, 2010, 12(6): 397-400. [32] Torres MJ, Montanez MI, Ariza A, et al.The role of IgE recognition in allergic reactions to amoxicillin and clavulanic acid[J]. Clin Exp Allergy, 2016, 46(2): 264-274. [33] 朱扣柱, 陈艳华, 洪远. 注射用哌拉西林钠他唑巴坦钠致小儿重症药疹1例[J]. 中国药物警戒, 2019, 16(9): 568-569. |